SUMMARY AND CONCLUSION

Similar documents
STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

REVISION OF MONOGRAPH ON TABLETS. Tablets

Pharmaceutical Preparation For Internal Use

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS

The unlocked synergy of DFE Pharma MCC

DESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE

MUPS (Multiple Unit Pellet System) Tablets A Brief Review

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels

Excipient Considerations for Continuous Manufacturing Implementation

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Easy, fast and reliable!

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

Easy, fast and reliable!

Fang Liu University of Hertfordshire

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

CHEWABLE SOFTGEL TECHNOLOGY

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Tablets that melt in the mouth:

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Routes of drug administration

FORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL

ORAL DOSAGE OVERVIEW

Re-compaction properties of lactose and microcrystalline cellulose

EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients

OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE. Technical brochure MicroceLac 100

UNIT 2 SOLID AND LIQUID DOSAGE FORMS

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

CONSIDERATION OF THE END USER AND THE LIMITATIONS DURING THE ORAL ADMINISTRATION DRUG DESIGN: CHALLENGE IN DIFFERENT AGE GROUPS

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

A matter of timing. ensure optimal delivery for acid-sensitive products. capsugel.com

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

LAB.2. Tablet Production Methods

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

YOUR ORAL SOLID DOSE. In pursuit of excipient excellence

ph Dependent Drug Delivery System: Review

Assessment of Human Pharmaceutical Products Registered in Kenya by Route of Administration and Type of Dosage Form

Long-Term Care Updates

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

SCIENTIFIC DISCUSSION. Efavirenz

Designed and manufactured specifically for pharmaceutical capsule filling

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

Principals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy

Formulation factors affecting acceptability of oral medicines in children

Food supplement manufacture

innovative products. faster to market. reliably supplied.

905 UNIFORMITY OF DOSAGE UNITS

Parenteral Products. By: Howida Kamal, Ph.D

Challenges in Developing Stable and Efficient Probiotic Formulations

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Source.

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

AUSTRALIAN MADE CAMPAIGN LIMITED

EVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data

Solid and sterile finished dosage forms. Delivered.

BUCCAL DRUG DELIVERY SYSTEM

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

A study of compressibility and compactibility of directly compressible tableting materials containing tramadol hydrochloride

Large scale production

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

Studies of Rapidly Disintegrating Tablets in the Oral Cavity Using Co-ground Mixtures of Mannitol with Crospovidone

STARCH Application Data

Emulsions. Purpose of emulsions and of emulsification:

CONTROLLED-RELEASE & SUSTAINED-RELEASE DOSAGE FORMS. Pharmaceutical Manufacturing-4

Opadry Enteric. Application Data. Drug Release from Acrylic-Based Opadry Enteric (94 Series) Coated Tablets INTRODUCTION MATERIALS AND METHODS

Protection and Processing of a Highly Hygroscopic Herbal Extract by Drug Layering and Film Coating

Is the science that study relation of physicochemical properties of drug, dosage form, & route of administration on rate and extent of drug

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

Formulation and evaluation of fast dissolving tablet of aceclofenac

KING KHALID UNIVERSITY

A Layperson s Guide to Pediatric Formulation Development

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

SENTRY TM POLYOX Water Soluble Resins

Packing and cohesive properties of some locally extracted starches

The Particle Design of Cellulose and the Other Excipients for a Directly Compressible Filler-Binder

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

Chapter 2 Rationale and Objective

Information about the Do Not Crush List. Hard Copy Version $60 charge including GST Plastic display folder 44 pages

Gellan Gum. Rm.1702, West Unit, No. 41, Donghai Xi Rd, Qingdao, China Post Code:

The binding performance of DFE Pharma Starch

Formulation and evaluation of oral dispersible tablets of aripiprazole

Physical Pharmacy. Interfacial phenomena. Khalid T Maaroof MSc. Pharmaceutical sciences School of pharmacy Pharmaceutics department

Primellose is an excellent choice as superdisintegrant in ODT applications

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

Compounding Options in Women s Health: Dosage Forms

Formulation and Evaluation

International Journal of Pharma and Bio Sciences V1(1)2010 FORMULATION AND EVALUATION OF ROSIGLITAZONE MOUTH DISSOLVING TABLET

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LIQUID PREPARATIONS FOR ORAL USE

SCIENTIFIC DISCUSSION

Topical Preparations

Research Article Development and Evaluation of a Novel Pellet-Based Tablet System for Potential Colon Delivery of Budesonide

Formulation and evaluation of immediate release salbutamol sulphate

Transcription:

SUMMARY AND CONCLUSION

8 SUMMARY AND CONCLUSIONS In spite of the many challenges faced by researchers while designing an effective, reproducible and stable dosage form, oral dosage forms continued to maintain a prominent position even in 21 ^' century. Improving patient comfort is basic need and a well-known strategy to improve patient compliance. Whatever the oral dosage forms, a special attention is attracted to the class of patient's i.e. children and elderly who has lot of difficulty in swallowing. Hence most of the products for children are formulated in complex dosage forms like syrups or suppositories. It is noted that for essential drugs such as Theophylline and Valporic acid, the exact dose should be administered with SR characteristics to achieve patient compliance and desired therapeutic effects that are not possible with syrups or suppositories. The prepared formulation is convenient dosage form which will improve children comfort and compliance. Among all possible oral SR systems currently in the market, multiparticulates are becoming more and more popular. They offer a convenient form to Pharmaceutical development and attracts the patients. Altogether, it represents one of the most desirable options for a profit perspective. One approach to design oral SR system is to coat drug loaded pellets with a polymer that regulate their drug release rate. Such coated pellets can be filled in hard gelatin capsules or compacted into Multiple-Unit tablets. Such tablets are normally intended to disintegrate in discrete pellets in the gastrointestinal tract and the drug should be subsequently released in a sustained manner from the individual pellets. One challenge in the production of Multiple-Unit tablets is the maintenance of desired drug release after compaction, as the application of compressional pressure can lead to structural changes in the film coating and, consequently, altered drug release. The compression induced changes in the structure of a film coafing can be restricted mainly by controlling the formulation factors, such as type, amount and form of Cushioning Agents, the method of production of pellets, and the type and amount of functional film coating material applied on the pellets. 192

Various fillers were evaluated individually and in combination for providing the Cushioning effect to pellets and developing a tablet with desired characters. It was observed that MCC PH 101 along with lactose monohydrate at 1:1 concentration produces the tablet with desired characters and provides the cushioning effect to the pellets to retain the SR properties. The 40:60 ratio of cushioning agent to pellets provided the Cushioning effect to pellets but failed to produce the tablet with desirable characteristics. Ratio of 50:50 and high of cushioning agent to pellets provided the desired characters to pellets as well as to the tablets that were resultant due to both the plastic deformation and fragmentation nature of MCC and lactose monohydrate respectively. MCC on compaction preferentially get deformed plastically and provides the cushioning effect to the pellets. Further it forms mechanical interlocking to produce the tablet with desired mechanical strength that disintegrate quickly when came in contact with water. Whereas lactose monohydrate on compaction preferentially gets deforms by fragmentation and provides cushioning effect while the weaker bonding in the particles along with MCC provides the desired tablet characters. One potential problem that was believed to be due to the incorporation of cushioning agents in powder form is segregation, owing to the difference in particle size. But the content uniformity studies of tablets revealed that at 60:40 ratio of powdered cushioning agent to pellets, no segregation was possible which may be due to the percolation theory of powders. Whereas, the newer sophisticated felling techniques can manage the segregation problem if any. Tablets prepared by using cushioning agent as granule or soft pellet form, was unable to cushion the pellets and provide the desired characters to the tablets. It may be due to the interruptions in the transmission of compressional forces from the surface of pellets. Functional film coating materials on the pellets also influences the release of drug after compression. It was revealed in the study that cellulosic coating materials were unable to resist the compressional forces whereas methacrylic co-polymers resist the forces. Further more aqueous dispersions of methacrylic co-polymers showed high resilience as that of cellulosic materials thereby providing resistance from destructive compressional forces. The aqueous dispersions because of their flexibility attain the deformed shape of pellet and thus preventing damage to the coating. The coated pellets at high concentration of coatings increases the resistance to compressional changes. 193

High dose drugs are poor candidate for SR drug delivery system due to its bulky size. Disintegrating Multiple-Unit tablet provides a resource to deliver high dose drugs like Metformin in SR form, by disintegrating the high size tablet containing SR pellets of drug in-vitro in water just before swallowing. Complete emptying of pellets from container into mouth which is needed that can be achieved by forming uniform dispersion of multiparticulates in-vitro. Viscosity modifiers were added to achieve dispersion of pellets in the vehicle. The studies showed that addition of water should disintegrate the tablet instantaneously to liberate the pellets thereafter increasing the viscosity of preparation. This can be achieved by using viscosity modifiers in granule form containing MCC. The powdered form of viscosity modifier forms a swollen layer along the tablet and prevents further penetration of water in the tablet thereby retards the disintegration of tablet. Whereas granule form of viscosity modifiers get liberated after disintegration of tablet that then disintegrate due to MCC to liberate small particles of viscosity modifier and increases the viscosity of dispersion to the desired level. It was also observed that CMC sodium at 01 % concentration was able to increase the viscosity in the desired range quickly. In the present study the preparation of disintegrating Multiple-Unit tablets along with combination of drugs with different release characteristics has been investigated with the intension of gaining a deeper understanding of some of the factors that influences the properties of pellets and tablets. In particular, the compression behavior of pellets constituting the tablets and the consequent effect on the drug release was studied. The solid dosage forms increases the stability of drug products whereas preference of liquefied preparations among pediatric and geriatric patients could substantially increase patient compliance. SR disintegrating Multiple-Unit tablet dosage forms possess the advantages of both the systems as well as the efficacy and accuracy of dosage administration is possible. Although this category of dosage form is still considered to be in its infancy, the trend towards multiparticulate tablet preparations and the necessity of liquefied dosage forms for specific patient groups will ensure increasing growth in the development and application of this type of dosage form. The prepared dosage form was satisfactory and acceptable as it disintegrate rapidly to liberate the intact individual pellets. Photomicrographs showed 194

that most pellets had undergone a certain degree of deformation on compression without any substantial damage to the SR pellets that was confirmed from the release profile of drug from tablet. The purpose of this study was to produce Multiple-Unit tablets containing the polymer coated pellets while maintaining the same release profile as that of uncompacted pellets. It was concluded from the study that coated pellets would be protected from fracture during compaction by the addition of proper type, form and proportion of cushioning agents, protective SR coating film and method of pellet formation, thereby maintaining the release profile of uncompacted coated pellets. The aim of this study was also to investigate the influence of formulation and process parameters on the tablet properties. Thus from the results it was shown that with careful optimization of formulation variables, it is possible to design a rapidly disintegrating SR Multiple-Unit tablet drug delivery system containing drug combinations for oral administration comprising compacted polymer coated pellets containing high dose drug. The findings of the present study will contribute to the knowledge of the parameters which influence the properties of such disintegrating Multiple-Unit tablets. 195